IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways

Table 3

Association of IL-17 expression with disease recurrence among the patients with LC .

IL-17 expression	Recurrence number/all patients’ number	aHR^1 (95% CI)
Low^2	8/38	1.00
High	7/22	3.29 (2.73-8.75)	0.028

¹Hazard ratio adjusted for age, sex, tumor size, TNM stage, LNM, and differentiation. ²Reference group (the median of expression as a cut-off point in patients without recurrence). LC: laryngeal cancer; TNM: tumor node metastasis; LNM: lymph node metastasis.